Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes-Reference-Cited by-同舟云学术

Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes

Published:2021-06-30 Issue:600 Volume:13 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Md Dom Zaipul I.¹²^ORCID,Satake Eiichiro¹²^ORCID,Skupien Jan³,Krolewski Bozena¹²,O’Neil Kristina¹^ORCID,Willency Jill A.⁴^ORCID,Dillon Simon T.²⁵^ORCID,Wilson Jonathan M.⁴^ORCID,Kobayashi Hiroki¹²^ORCID,Ihara Katsuhito¹²,Libermann Towia A.²⁵,Pragnell Marlon⁶^ORCID,Duffin Kevin L.⁴^ORCID,Krolewski Andrzej S.¹²^ORCID

Affiliation:

1. Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.

2. Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.

3. Department of Metabolic Diseases, Jagiellonian University Medical College, 31-008 Krakow, Poland.

4. Diabetes and Complication Department, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46225, USA.

5. Genomics, Proteomics, Bioinformatics and Systems Biology Center, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

6. JDRF International, New York, NY 10281, USA.

Abstract

Global proteomics profiling identified FGF20, TNFSF12, and ANGPT1 as protective against progression of renal function decline in those with diabetes.

Funder

National Institutes of Health

JDRF